Jessica Phillips, MD
Adult Reconstructive Orthopaedic Surgery · Beaverton, ORNPI 1598127144
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (38.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 40.6% of the total. Reporting peaked in 2022 at $5,780 and has fallen 79.0% since, to $1,216 in 2025.
Across 42 payments — averaging $290.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$5K
- Liberty Surgical Inc.$5K
- Stryker$1K
- Johnson & Johnson$586
- Zimmer Biomet$452
- Medical Device Business Services, Inc.$88
- plus $36 from 1 others
What the payments were for
- Consulting fees$3,59930%
- Travel & lodging$1,93816%
- Food & beverage$1,91916%
- Education$4,74339%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 7 | $4,949 |
| Liberty Surgical Inc. | 2 | $4,743 |
| Stryker | 14 | $1,344 |
| Johnson & Johnson | 6 | $586 |
| Zimmer Biomet | 9 | $452 |
| Medical Device Business Services, Inc. | 3 | $88 |
| Steelhead Surgical Inc | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,199 in reported general payments places this provider in the 60th percentile of 20 adult reconstructive orthopaedic surgery providers in Oregon.
See all adult reconstructive orthopaedic surgery providers in Oregon →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 165 | $4,145 |
| Oxycodone Hcl | 137 | $1,178 |
| Cyclobenzaprine Hcl | 135 | $1,050 |
| Ondansetron Hcl | 126 | $642 |
| Pantoprazole Sodium | 123 | $625 |
| Cefadroxil | 42 | $365 |
| Diclofenac Sodium | 12 | $344 |
| Methylprednisolone | 24 | $169 |
| Amoxicillin | 36 | $118 |
| Meloxicam | 20 | $83 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Beaverton
- Ryland KaganPortland$154K
- Thomas HuffPortland$95K
- James VanhorneGrants Pass$42K
- Gustav FischerPortland$24K
- James HoMedford$15K
- Lily WoodPortland$14K
- Daniel CowleyGrants Pass$12K
- Mary SkrzynskiBend$10K
- Mark MildrenEugene$10K
- Gerald AggreyEugene$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.